NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function
The Journal of Immunology · 15.01.2024 · 212 (2) · 258-270
DOI: 10.4049/jimmunol.2200691 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 11.12.2023. Verfasst von Jing Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, NADPH Oxidase 2, Reactive Oxygen Species. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Oxidants participate in lymphocyte activation and function. We previously demonstrated that eliminating the activity of NADPH oxidase 2 (NOX2) significantly impaired the effectiveness of autoreactive CD8+ CTLs. However, the molecular mechanisms impacting CD8+ T cell function remain unknown. In the present study, we examined the role of NOX2 in both NOD mouse and human CD8+ T cell function. Genetic ablation or chemical inhibition of NOX2 in CD8+ T cells significantly suppressed activation-induced expression of the transcription factor T-bet, the master transcription factor of the Tc1 cell lineage, and T-bet target effector genes such as IFN-γ and granzyme B. Inhibition of NOX2 in both human and mouse CD8+ T cells prevented target cell lysis. We identified that superoxide generated by NOX2 must be converted into hydrogen peroxide to transduce the redox signal in CD8+ T cells. Furthermore, we show that NOX2-generated oxidants deactivate the tumor suppressor complex leading to activation of RheB and subsequently mTOR complex 1. These results indicate that NOX2 plays a nonredundant role in TCR-mediated CD8+ T cell effector function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL.
- Department of Medicine, University of Florida, Gainesville, FL.
- Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL.
- Morsani College of Medicine, University of South Florida, Tampa, FL.
- Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University, Baltimore, MD.
- Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, FL.
ORCID-Profile: Jing Chen, Anna V Chernatynskaya, Brittney Newby, Todd M Brusko, Nadine Morgan, Hubert M Tse, Clayton E Mathews
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- HHS | National Institutes of Health
- Horizon Therapeutics
Zitieren
APA
Chen, J., Liu, C., Chernatynskaya, A. V., Newby, B., Brusko, T. M., Xu, Y., Barra, J. M., Morgan, N., Santarlas, C., Reeves, W. H., Tse, H. M., Leiding, J. W., & Mathews, C. E. (2024). NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function. The Journal of Immunology, 212(2), 258-270. https://doi.org/10.4049/jimmunol.2200691
Vancouver
Chen J, Liu C, Chernatynskaya AV, Newby B, Brusko TM, Xu Y, et al. NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function. The Journal of Immunology. 2024;212(2):258-270. doi:10.4049/jimmunol.2200691
BibTeX
@article{Chen2024,
author = {Chen, Jing and Liu, Chao and Chernatynskaya, Anna V and Newby, Brittney and Brusko, Todd M and Xu, Yuan and Barra, Jessie M and Morgan, Nadine and Santarlas, Christopher and Reeves, Westley H and Tse, Hubert M and Leiding, Jennifer W and Mathews, Clayton E},
title = {NADPH Oxidase 2–Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function},
journal = {The Journal of Immunology},
year = {2024},
volume = {212},
number = {2},
pages = {258--270},
doi = {10.4049/jimmunol.2200691}
}
EUVIMED